Non-haematological grade 1 and 2 adverse events of frontline CPX-351 in patients with myelodysplastic syndromes

Research output: Contribution to journal › Letter › peer-review

ASJC Scopus subject areas

@article{de151f0935964cc5ab593d8b99d7258c,

title = "Non-haematological grade 1 and 2 adverse events of frontline CPX-351 in patients with myelodysplastic syndromes",

author = "Koji Sasaki",

year = "2023",

month = nov,

doi = "10.1016/S2352-3026(23)00272-7",

language = "English (US)",

volume = "10",

pages = "e872",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Elsevier Limited",

number = "11",

}

TY - JOUR

T1 - Non-haematological grade 1 and 2 adverse events of frontline CPX-351 in patients with myelodysplastic syndromes

AU - Sasaki, Koji

PY - 2023/11

Y1 - 2023/11

UR - https://www.scopus.com/pages/publications/85174938769

UR - https://www.scopus.com/pages/publications/85174938769#tab=citedBy

U2 - 10.1016/S2352-3026(23)00272-7

DO - 10.1016/S2352-3026(23)00272-7

M3 - Letter

C2 - 37914477

AN - SCOPUS:85174938769

SN - 2352-3026

VL - 10

SP - e872

JO - The Lancet Haematology

JF - The Lancet Haematology

IS - 11

ER -